CD207
C-type lectin domain family 4 member K
Also known as: CLC4K_HUMAN, CLEC4K, Langerin
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJ71
- Gene
- CD207
- Ensembl
- ENSG00000116031
- Chromosome
- 2
- Canonical length
- 328 aa
- Protein class
- CD markers, Disease related genes, Predicted membrane proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is expressed only in Langerhans cells which are immature dendritic cells of the epidermis and mucosa. It is localized in the Birbeck granules, organelles present in the cytoplasm of Langerhans cells and consisting of superimposed and zippered membranes. It is a C-type lectin with mannose binding specificity, and it has been proposed that mannose binding by this protein leads to internalization of antigen into Birbeck granules and providing access to a nonclassical antigen-processing pathway. Mutations in this gene result in Birbeck granules deficiency or loss of sugar binding activity. [provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
328 residues, UniProt reviewed canonical sequence.
>Q9UJ71|CD207
1 MTVEKEAPDA HFTVDKQNIS LWPREPPPKS GPSLVPGKTP TVRAALICLT LVLVASVLLQ
61 AVLYPRFMGT ISDVKTNVQL LKGRVDNIST LDSEIKKNSD GMEAAGVQIQ MVNESLGYVR
121 SQFLKLKTSV EKANAQIQIL TRSWEEVSTL NAQIPELKSD LEKASALNTK IRALQGSLEN
181 MSKLLKRQND ILQVVSQGWK YFKGNFYYFS LIPKTWYSAE QFCVSRNSHL TSVTSESEQE
241 FLYKTAGGLI YWIGLTKAGM EGDWSWVDDT PFNKVQSVRF WIPGEPNNAG NNEHCGNIKA
301 PSLQAWNDAP CDKTFLFICK RPYVPSEPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD207 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 83 nTPM
Expression across tissuesHPA
Tissue
- skin: 83 nTPM
- esophagus: 17 nTPM
- retina: 5.1 nTPM
- small intestine: 4.6 nTPM
- tonsil: 4.5 nTPM
- spleen: 3.5 nTPM
Single-cell type
- macrophages: 16 nCPM
- cdc: 6.8 nCPM
- retinal pigment epithelial cells: 4.3 nCPM
- suprabasal keratinocytes: 2.2 nCPM
- late spermatids: 2 nCPM
- breast myoepithelial cells: 1.7 nCPM
Immune cell
- myeloid DC: 1.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 0.3 nTPM
- cerebral cortex: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- cerebellum: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CD207.
Disease | AllUniProt
Conditions CD207 is implicated in, by any mechanism.
- Birbeck granule deficiency (BIRGD) MIM:613393
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.02
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD207 as an antibody target. Whether an autoantibody or antibody against CD207 could matter depends on whether native CD207 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD207 is annotated at the cell surface, where native CD207 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD207 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...